Skip to Content

SOLVENT-DILUENT (FOR MELPHALAN INJECTION)

Active substance(s): NOT APPLICABLE

View full screen / Print PDF » Download PDF ⇩
Transcript


 
  
Package Leaflet: Information for the User

Melphalan 50 mg Powder
and Solvent for Solution for
Injection/Infusion.
melphalan
Read all of this leaflet carefully before you start using this medicine
Ě .HHSWKLVOHDIOHW Ě ,I\RXKDYHDQ\IXUWKHUTXHVWLRQVDERXW\RXULOOQHVVRU\RXUPHGLFLQHDVN
\RXUGRFWRURUQXUVH
Ě ,IDQ\RIWKHVLGHHIIHFWVJHWVHULRXVRULI\RXQRWLFHDQ\VLGHHIIHFWVQRW
OLVWHGLQWKLVOHDIOHWSOHDVHWHOO\RXUGRFWRUQXUVHRUSKDUPDFLVW
In this leaflet:
1 :KDW0HOSKDODQLVDQGZKDWLWLVXVHGIRU
2 %HIRUH\RXKDYH0HOSKDODQ
3 +RZWRKDYH0HOSKDODQ
4 3RVVLEOHVLGHHIIHFWV
5 +RZWRVWRUH0HOSKDODQ
6 )XUWKHULQIRUPDWLRQ
1 What Melphalan is and what it is used for
0HOSKDODQLQMHFWLRQFRQWDLQVDPHGLFLQHFDOOHGPHOSKDODQ7KLVEHORQJVWRD
JURXSRIPHGLFLQHVFDOOHGF\WRWR[LFV DOVRFDOOHGFKHPRWKHUDS\ 0HOSKDODQ
LVXVHGWRWUHDWFDQFHU,WZRUNVE\UHGXFLQJWKHQXPEHURIDEQRUPDOFHOOV
\RXUERG\PDNHV
0HOSKDODQLVXVHGIRU
Ě Multiple myeloma ĘDW\SHRIFDQFHUWKDWGHYHORSVIURPFHOOVLQWKH
ERQHPDUURZFDOOHGSODVPDFHOOV3ODVPDFHOOVKHOSWRILJKWLQIHFWLRQDQG
GLVHDVHE\SURGXFLQJDQWLERGLHV
Ě $GYDQFHGcancer of the ovaries
Ě Childhood neuroblastomaFDQFHURIWKHQHUYRXVV\VWHP
Ě Malignant melanoma ĘVNLQFDQFHU
Ě Soft tissue sarcoma ĘFDQFHURIWKHPXVFOHIDWILEURXVWLVVXHEORRG
YHVVHOVRURWKHUVXSSRUWLQJWLVVXHRIWKHERG\
$VN\RXUGRFWRULI\RXZRXOGOLNHPRUHH[SODQDWLRQDERXWWKHVHGLVHDVHV
2 Before you have Melphalan
Do not have Melphalan if:
Ě  LQJUHGLHQWVRI0HOSKDODQLQMHFWLRQ 6HHVHFWLRQ)XUWKHULQIRUPDWLRQ
'RQRWKDYH0HOSKDODQLIWKHDERYHDSSOLHVWR\RX,I\RXDUHQRWVXUHWDON
WR\RXUGRFWRURUQXUVHEHIRUHKDYLQJ0HOSKDODQ

Melphalan 50 mg Powder
and Solvent for Solution for
Injection/Infusion.
melphalan

Take special care with Melphalan
%HIRUH\RXXVH0HOSKDODQWHOO\RXUGRFWRURUQXUVHLI
Ě \RXKDYHKDGUDGLRWKHUDS\RUFKHPRWKHUDS\QRZRUUHFHQWO\
Ě \RXKDYHDNLGQH\SUREOHP
,I\RXDUHQRWVXUHLIDQ\RIWKHDERYHDSSO\WR\RXWDONWR\RXUGRFWRURU
QXUVHEHIRUHKDYLQJ0HOSKDODQ
Taking other medicines
3OHDVHWHOO\RXUGRFWRURUQXUVHLI\RXDUHWDNLQJRUKDYHUHFHQWO\WDNHQDQ\
RWKHUPHGLFLQHVLQFOXGLQJPHGLFLQHVREWDLQHGZLWKRXWDSUHVFULSWLRQ7KLV
LQFOXGHVKHUEDOPHGLFLQHV
,QSDUWLFXODUWHOO\RXUGRFWRURUQXUVHLI\RXDUHWDNLQJDQ\RIWKHIROORZLQJ
Ě RWKHUF\WRWR[LFGUXJV FKHPRWKHUDS\ 
Ě QDOLGL[LFDFLG DQDQWLELRWLFXVHGWRWUHDWXULQDU\WUDFWLQIHFWLRQV
Ě FLFORVSRULQ XVHGWRSUHYHQWUHMHFWLRQRIRUJDQVRUWLVVXHVIROORZLQJD
WUDQVSODQWRUWRWUHDWFHUWDLQVNLQFRQGLWLRQVOLNHSVRULDVLVDQGHF]HPDRU
WRWUHDWUKHXPDWRLGDUWKULWLV 
Having vaccines while you are taking Melphalan
,I\RXDUHJRLQJWRKDYHDYDFFLQDWLRQVSHDNWR\RXUGRFWRURUQXUVHEHIRUH
\RXKDYHLW7KLVLVEHFDXVHVRPHYDFFLQHV OLNHSROLRPHDVOHVPXPSVDQG
UXEHOOD PD\JLYH\RXDQLQIHFWLRQLI\RXKDYHWKHPZKLOVW\RXDUHEHLQJ
WUHDWHGZLWK0HOSKDODQ
Pregnancy and breast-feeding
'RQRWKDYH0HOSKDODQLI\RXDUHSODQQLQJWRKDYHDEDE\7KLVDSSOLHVWR
ERWKPHQDQGZRPHQ0HOSKDODQPD\KDUP\RXUVSHUPRUHJJV5HOLDEOH
FRQWUDFHSWLYHSUHFDXWLRQVPXVW EHWDNHQWRDYRLGSUHJQDQF\ZKLOVW\RXRU
\RXUSDUWQHUDUHKDYLQJWKLVLQMHFWLRQ$VN\RXUGRFWRUIRUDGYLFH
,I\RXDUHDOUHDG\SUHJQDQWLWLVLPSRUWDQWWRWDONWR\RXUGRFWRUEHIRUH
KDYLQJ0HOSKDODQ
'RQRWEUHDVWIHHGZKLOHKDYLQJ0HOSKDODQ$VN\RXUGRFWRURUPLGZLIHIRU
DGYLFH
3 How to have Melphalan
0HOSKDODQ VKRXOG RQO\ EH SUHVFULEHG IRU \RX E\ D VSHFLDOLVW GRFWRU ZKR LV
H[SHULHQFHGLQWUHDWLQJEORRGSUREOHPVRUFDQFHU
0HOSKDODQLQMHFWLRQFDQEHJLYHQ
Ě DVDQLQIXVLRQLQWR\RXUYHLQ
Ě DVDSHUIXVLRQWRDSDUWLFXODUSDUWRI\RXUERG\WKURXJKDQDUWHU\
0HOSKDODQGHSHQGVRQ
Ě \ RXUERG\ZHLJKWRUERG\VXUIDFHDUHD DVSHFLILFPHDVXUHPHQWWDNLQJLQWR
DFFRXQW\RXUZHLJKWDQG\RXUVL]H
Ě RWKHUGUXJV\RXDUHKDYLQJ
Ě \RXUGLVHDVH
Ě \RXUDJH
Ě ZKHWKHURUQRW\RXKDYHNLGQH\SUREOHPV
:KHQ\RXDUHJLYHQ0HOSKDODQ\RXUGRFWRUZLOOWDNHUHJXODUEORRGWHVWV7KLV
LV WR FKHFN WKH QXPEHU RI FHOOV LQ \RXU EORRG FKDQJH\RXUGRVHDVDUHVXOWRIWKHVHWHVWV

Soft tissue sarcoma: +\SHUWKHUPLFUHJLRQDOSHUIXVLRQZLWK0HOSKDODQKDV
EHHQXVHGLQWKHPDQDJHPHQWRIDOOVWDJHVRIORFDOLVHGVRIWWLVVXHVDUFRPD
XVXDOO\LQFRPELQDWLRQZLWKVXUJHU\0HOSKDODQKDVDOVREHHQJLYHQZLWK
DFWLQRP\FLQ'DQGWKHVFLHQWLILFOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOV
RIGRVDJHUHJLPHQV$W\SLFDOGRVHUDQJHIRUXSSHUH[WUHPLW\SHUIXVLRQV
LVWRPJNJERG\ZHLJKWDQGIRUORZHUH[WUHPLW\SHUIXVLRQVLV
WRPJNJERG\ZHLJKW
Advanced neuroblastoma: 'RVHVRIEHWZHHQDQGPJPERG\
VXUIDFHDUHD VRPHWLPHVGLYLGHGHTXDOO\RYHUFRQVHFXWLYHGD\V WRJHWKHU
ZLWKDXWRORJRXVERQHPDUURZUHVFXHKDYHEHHQXVHGHLWKHUDORQHRULQ
FRPELQDWLRQZLWKUDGLRWKHUDS\DQGRURWKHUF\WRWR[LFGUXJV

Dosage and administration
0HOSKDODQLVDF\WRWR[LFGUXJZKLFKIDOOVLQWRWKHJHQHUDOFODVVRIDON\ODWLQJ
DJHQWV,WVKRXOGEHSUHVFULEHGRQO\E\SK\VLFLDQVH[SHULHQFHGLQWKH
PDQDJHPHQWRIPDOLJQDQWGLVHDVHZLWKVXFKDJHQWV
6LQFH0HOSKDODQLVP\HORVXSSUHVVLYHIUHTXHQWEORRGFRXQWVDUHHVVHQWLDO
GXULQJWKHUDS\DQGWKHGRVDJHVKRXOGEHGHOD\HGRUDGMXVWHGLIQHFHVVDU\
VHHPrecautionV 
Multiple myeloma: 0HOSKDODQ,QMHFWLRQKDVEHHQXVHGRQDQ
LQWHUPLWWHQWEDVLVDORQHRULQFRPELQDWLRQZLWKRWKHUF\WRWR[LFGUXJVDW
GRVHVYDU\LQJEHWZHHQPJPERG\VXUIDFHDUHDDQGPJPERG\
VXUIDFHDUHDJLYHQDWLQWHUYDOVRIEHWZHHQWRZHHNV$GGLWLRQDOO\
DGPLQLVWUDWLRQRISUHGQLVRQHKDVEHHQLQFOXGHGLQDQXPEHURIUHJLPHQV
7KHOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUSUHFLVHGHWDLOVRQWUHDWPHQWSURWRFROV
:KHQXVHGDVDVLQJOHDJHQWDW\SLFDOLQWUDYHQRXVGRVDJHVFKHGXOH
LVPJNJERG\ZHLJKW PJPERG\VXUIDFHDUHD UHSHDWHGDW
DSSURSULDWHLQWHUYDOV HJRQFHHYHU\ZHHNV SURYLGHGWKHUHKDVEHHQ
UHFRYHU\RIWKHSHULSKHUDOEORRGFRXQWGXULQJWKLVSHULRG
+LJKGRVHUHJLPHQVJHQHUDOO\HPSOR\VLQJOHLQWUDYHQRXVGRVHVRI
EHWZHHQDQGPJPERG\VXUIDFHDUHD DSSUR[LPDWHO\WR
PJNJERG\ZHLJKW EXWDXWRORJRXVERQHPDUURZUHVFXHEHFRPHV
HVVHQWLDOIROORZLQJGRVHVLQH[FHVVRIPJPERG\VXUIDFHDUHD
,QFDVHVRIUHQDOLPSDLUPHQWWKHGRVHVKRXOGEHUHGXFHGE\ILIW\SHUFHQW
VHHDosage in renal impairmenW ,QYLHZRIWKHVHYHUHP\HORVXSSUHVVLRQ
LQGXFHGE\KLJKGRVH0HOSKDODQ,QMHFWLRQWUHDWPHQWVKRXOGEH
FRQILQHGWRVSHFLDOLVWFHQWUHVZLWKWKHDSSURSULDWHIDFLOLWLHVDQGRQO\EH
DGPLQLVWHUHGE\H[SHULHQFHGFOLQLFLDQV VHHPrecautionV 
Ovarian adenocarcinoma: :KHQXVHGLQWUDYHQRXVO\DVDVLQJOHDJHQWD
GRVHRIPJNJERG\ZHLJKW DSSUR[LPDWHO\PJPERG\VXUIDFHDUHD 
JLYHQDWLQWHUYDOVRIZHHNVKDVRIWHQEHHQXVHG
:KHQFRPELQHGZLWKRWKHUF\WRWR[LFGUXJVLQWUDYHQRXVGRVHVRIEHWZHHQ
DQGPJNJERG\ZHLJKW WRPJPERG\VXUIDFHDUHD KDYH
EHHQXVHGDWLQWHUYDOVRIWRZHHNV

Preparation of Melphalan Injection Solution: 0HOSKDODQ,QMHFWLRQVKRXOG
EHSUHSDUHG$752207(03(5$785(E\UHFRQVWLWXWLQJWKHIUHH]HGULHG
SRZGHUZLWKWKH6ROYHQW'LOXHQWSURYLGHG
PORIWKHYHKLFOHVKRXOGEHDGGHGTXLFNO\DVDVLQJOHTXDQWLW\LQWR
WKHYLDOFRQWDLQLQJWKHIUHH]HGULHGSRZGHUDQGLPPHGLDWHO\VKDNHQ
9,*25286/< IRUDWOHDVWVHFRQGV XQWLODFOHDUVROXWLRQZLWKRXWYLVLEOH
SDUWLFOHVLVREWDLQHG(DFKYLDOPXVWEHUHFRQVWLWXWHGLQGLYLGXDOO\LQWKLV
PDQQHU7KHUHVXOWLQJVROXWLRQFRQWDLQVWKHHTXLYDOHQWRIPJSHUPO
DQK\GURXVPHOSKDODQDQGKDVDS+RIDSSUR[LPDWHO\
0HOSKDODQ,QMHFWLRQVROXWLRQKDVOLPLWHGVWDELOLW\DQGVKRXOGEHSUHSDUHG
LPPHGLDWHO\EHIRUHXVH$Q\XQXVHGVROXWLRQUHPDLQLQJDIWHURQHKRXU
VKRXOGEHGLVFDUGHG(See Pharmaceutical precautions).
7KHUHFRQVWLWXWHGVROXWLRQVKRXOGQRWEHUHIULJHUDWHGDVWKLVZLOOFDXVH
SUHFLSLWDWLRQ
Parenteral administration: ([FHSWLQFDVHVZKHUHUHJLRQDODUWHULDO
SHUIXVLRQLVLQGLFDWHG0HOSKDODQ,QMHFWLRQLVIRULQWUDYHQRXVXVHRQO\
)RULQWUDYHQRXVDGPLQLVWUDWLRQLWLVUHFRPPHQGHGWKDW0HOSKDODQ,QMHFWLRQ
VROXWLRQLVLQMHFWHGVORZO\LQWRDIDVWUXQQLQJLQIXVLRQVROXWLRQYLDDVZDEEHG
LQMHFWLRQSRUW
,IGLUHFWLQMHFWLRQLQWRDIDVWUXQQLQJLQIXVLRQLVQRWDSSURSULDWH0HOSKDODQ
,QMHFWLRQVROXWLRQPD\EHDGPLQLVWHUHGGLOXWHGLQDQLQIXVLRQEDJ
0HOSKDODQLVQRWFRPSDWLEOHZLWKLQIXVLRQVROXWLRQVFRQWDLQLQJGH[WURVH
DQGLWLVUHFRPPHQGHGWKDW21/<6RGLXP&KORULGH,QWUDYHQRXV,QIXVLRQ
ZYLVXVHG
:KHQIXUWKHUGLOXWHGLQDQLQIXVLRQVROXWLRQ0HOSKDODQ,QMHFWLRQKDV
UHGXFHGVWDELOLW\DQGWKHUDWHRIGHJUDGDWLRQLQFUHDVHVUDSLGO\ZLWK
ULVHLQWHPSHUDWXUH,IDGPLQLVWUDWLRQRFFXUVDWDURRPWHPSHUDWXUHRI
DSSUR[LPDWHO\Ń&WKHWRWDOWLPHIURPSUHSDUDWLRQRIWKH,QMHFWLRQVROXWLRQ
WRWKHFRPSOHWLRQRILQIXVLRQVKRXOGQRWH[FHHGKRXUV
6KRXOGDQ\YLVLEOHWXUELGLW\RUFU\VWDOOL]DWLRQDSSHDULQWKHUHFRQVWLWXWHGRU
GLOXWHGVROXWLRQVWKHSUHSDUDWLRQPXVWEHGLVFDUGHG
&DUHVKRXOGEHWDNHQWRDYRLGSRVVLEOHH[WUDYDVDWLRQRI0HOSKDODQDQGLQ
FDVHVRISRRUSHULSKHUDOYHQRXVDFFHVVFRQVLGHUDWLRQVKRXOGEHJLYHQWRXVH
RIDFHQWUDOYHQRXVOLQH
,IKLJKGRVH0HOSKDODQ,QMHFWLRQLVDGPLQLVWHUHGZLWKRUZLWKRXWDXWRORJRXV
ERQHPDUURZWUDQVSODQWDWLRQDGPLQLVWUDWLRQYLDDFHQWUDOYHQRXVOLQHLV
UHFRPPHQGHG
)RUUHJLRQDODUWHULDOSHUIXVLRQWKHOLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOHG
PHWKRGRORJ\
Use in children: 0HOSKDODQDWFRQYHQWLRQDOGRVDJHLVRQO\UDUHO\LQGLFDWHG
LQFKLOGUHQDQGGRVDJHJXLGHOLQHVFDQQRWEHVWDWHG
+LJKGRVH0HOSKDODQ,QMHFWLRQLQDVVRFLDWLRQZLWKERQHPDUURZUHVFXHKDV
EHHQXVHGLQFKLOGKRRGQHXUREODVWRPDDQGGRVDJHJXLGHOLQHVEDVHGRQERG\
VXUIDFHDUHDDVIRUDGXOWVPD\EHXVHG
Use in the elderly: $OWKRXJK0HOSKDODQLVIUHTXHQWO\XVHGDWFRQYHQWLRQDO
GRVDJHLQWKHHOGHUO\WKHUHLVQRVSHFLILFLQIRUPDWLRQDYDLODEOHUHODWLQJWRLWV
DGPLQLVWUDWLRQWRWKLVSDWLHQWVXEJURXS
([SHULHQFHLQWKHXVHRIKLJKGRVH0HOSKDODQLQHOGHUO\SDWLHQWVLVOLPLWHG
&RQVLGHUDWLRQVKRXOGWKHUHIRUHEHJLYHQWRHQVXUHDGHTXDWHSHUIRUPDQFH
VWDWXVDQGRUJDQIXQFWLRQEHIRUHXVLQJKLJKGRVH0HOSKDODQ,QMHFWLRQLQ
HOGHUO\SDWLHQWV
Dosage in renal impairment: 0HOSKDODQFOHDUDQFHWKRXJKYDULDEOHLV
GHFUHDVHGLQUHQDOLPSDLUPHQW
:KHQ0HOSKDODQ,QMHFWLRQLVXVHGDWFRQYHQWLRQDOLQWUDYHQRXVGRVDJH
WRPJPERG\VXUIDFHDUHD LWLVUHFRPPHQGHGWKDWWKHLQLWLDOGRVH
VKRXOGEHUHGXFHGE\LQSDWLHQWVZLWKPRGHUDWHWRVHYHUHUHQDO
LPSDLUPHQWDQGVXEVHTXHQWGRVDJHGHWHUPLQHGDFFRUGLQJWRWKHGHJUHHRI
KDHPDWRORJLFDOVXSSUHVVLRQ
)RUKLJKLQWUDYHQRXVGRVHVRI0HOSKDODQ WRPJPERG\VXUIDFHDUHD 
WKHQHHGIRUGRVHUHGXFWLRQGHSHQGVXSRQWKHGHJUHHRIUHQDOLPSDLUPHQW
ZKHWKHUDXWRORJRXVERQHPDUURZVWHPFHOOVDUHUHLQIXVHGDQGWKHUDSHXWLF
QHHG$VDJXLGHIRUPRGHUDWHWRVHYHUHUHQDOLPSDLUPHQW ('7$FOHDUDQFHWR
POPLQ DGRVHUHGXFWLRQRILVXVXDO$GHTXDWHK\GUDWLRQDQGIRUFHG
GLXUHVLVDUHDOVRQHFHVVDU\+LJKGRVH0HOSKDODQLVQRWUHFRPPHQGHGLQSDWLHQWV
ZLWKPRUHVHYHUHUHQDOLPSDLUPHQW ('7$FOHDUDQFHOHVVWKDQPOPLQ 

Malignant melanoma: +\SHUWKHUPLFUHJLRQDOSHUIXVLRQZLWK0HOSKDODQ
KDVEHHQXVHGDVDQDGMXYDQWWRVXUJHU\IRUHDUO\PDOLJQDQWPHODQRPDDQG
DVSDOOLDWLYHWUHDWPHQWIRUDGYDQFHGEXWORFDOLVHGGLVHDVH7KHVFLHQWLILF
OLWHUDWXUHVKRXOGEHFRQVXOWHGIRUGHWDLOVRISHUIXVLRQWHFKQLTXHDQGGRVDJH
XVHG$W\SLFDOGRVHUDQJHIRUXSSHUH[WUHPLW\SHUIXVLRQVLVWRPJNJ
ERG\ZHLJKWDQGIRUORZHUH[WUHPLW\SHUIXVLRQVLVWRPJNJERG\
ZHLJKW

Contra-indications, warnings, etc
Contra-indications: 0HOSKDODQVKRXOGQRWEHJLYHQWRSDWLHQWVZKRKDYH
VXIIHUHGDSUHYLRXVK\SHUVHQVLWLYLW\UHDFWLRQWRPHOSKDODQ
 
Precautions: 0(/3+$/$1,6$1$&7,9(&<7272;,&$*(17)25
  
86(81'(57+(',5(&7,212)3+<6,&,$16(;3(5,(1&(',17+(
$'0,1,675$7,212)68&+$*(176
,PPXQLVDWLRQXVLQJDOLYHRUJDQLVPYDFFLQHKDVWKHSRWHQWLDOWRFDXVH

To the Medical and Pharmaceutical Professions
Presentation
0HOSKDODQ,QMHFWLRQLVVXSSOLHGDVDXQLWSDFNFRPSULVLQJDYLDOFRQWDLQLQJD
IUHH]HGULHGSRZGHUDQGDYLDORIVROYHQWGLOXHQW(DFK0HOSKDODQYLDOFRQWDLQV
WKHHTXLYDOHQWRIPJRIPHOSKDODQLQWKHIRUPRIWKHK\GURFKORULGHDVD
VWHULOHZKLWHWRRIIZKLWHIUHH]HGULHGSRZGHUZKLFKLQFOXGHVPJSRYLGRQH
.(DFKYLDORIVROYHQWGLOXHQWSURYLGHVPORIEXIIHUVROXWLRQFRQWDLQLQJ
YYSURS\OHQHJO\FROZLWKVRGLXPFLWUDWHDQGHWKDQRO
Uses
0HOSKDODQ,QMHFWLRQDGPLQLVWHUHGE\UHJLRQDODUWHULDOSHUIXVLRQLVLQGLFDWHG
LQWKHWUHDWPHQWRIORFDOLVHGPDOLJQDQWPHODQRPDRIWKHH[WUHPLWLHVDQG
ORFDOLVHGVRIWWLVVXHVDUFRPDRIWKHH[WUHPLWLHV
0HOSKDODQ,QMHFWLRQDWFRQYHQWLRQDOLQWUDYHQRXVGRVDJHPD\EHXVHGLQWKH
WUHDWPHQWRI
multiple myeloma: 0HOSKDODQ,QMHFWLRQHLWKHUDORQHRULQFRPELQDWLRQ
ZLWKRWKHUF\WRWR[LFGUXJVLVDVHIIHFWLYHDVWKHRUDOIRUPXODWLRQLQWKH
WUHDWPHQWRIPXOWLSOHP\HORPD
ovarian cancer: 0HOSKDODQ,QMHFWLRQSURGXFHVDQREMHFWLYHUHVSRQVH
LQDSSUR[LPDWHO\ILIW\SHUFHQWRIWKHSDWLHQWVZLWKDGYDQFHGRYDULDQ
DGHQRFDUFLQRPDZKHQJLYHQDORQHRULQFRPELQDWLRQZLWKRWKHUF\WRWR[LFGUXJV
0HOSKDODQ,QMHFWLRQDWKLJKLQWUDYHQRXVGRVDJHPD\EHXVHGLQWKHWUHDWPHQWRI
multiple myeloma: FRPSOHWHUHPLVVLRQVKDYHEHHQDFKLHYHGLQXSWR
ILIW\SHUFHQWRISDWLHQWVJLYHQKLJKGRVH0HOSKDODQ,QMHFWLRQZLWKRU
ZLWKRXWDXWRORJRXVERQHPDUURZUHVFXHHLWKHUDVILUVWOLQHWUHDWPHQWRUWR
FRQVROLGDWHDUHVSRQVHWRFRQYHQWLRQDOF\WRUHGXFWLYHFKHPRWKHUDS\
neuroblastoma in childhood: KLJKGRVH0HOSKDODQ,QMHFWLRQZLWK
DXWRORJRXVERQHPDUURZUHVFXHKDVEHHQXVHGHLWKHUDORQHRUFRPELQHG
ZLWKUDGLRWKHUDS\DQGRURWKHUF\WRWR[LFGUXJVWRFRQVROLGDWHDUHVSRQVHWR
FRQYHQWLRQDOWUHDWPHQW$VLJQLILFDQWLQFUHDVHLQWKHGXUDWLRQRIGLVHDVHIUHH
VXUYLYDOZDVGHPRQVWUDWHGLQDSURVSHFWLYHUDQGRPLVHGWULDORIKLJKGRVH
0HOSKDODQ,QMHFWLRQYHUVXVQRIXUWKHUWUHDWPHQW

If you have more Melphalan than you need
PXFK,I\RXWKLQN\RXKDYHEHHQJLYHQWRRPXFKRUKDYHPLVVHGDGRVHWHOO
\RXUGRFWRURUQXUVH
4 Possible side effects
/LNHDOOPHGLFLQHV0HOSKDODQFDQFDXVHVLGHHIIHFWVDOWKRXJKQRWHYHU\ERG\
JHWVWKHP
If you get any of the following, talk to your specialist doctor or go to
hospital straight away:
Ě DOOHUJLFUHDFWLRQWKHVLJQVPD\LQFOXGH
  DUDVKOXPSVRUKLYHVRQWKHVNLQ
  VZROOHQIDFHH\HOLGVRUOLSV
  VXGGHQZKHH]LQHVVDQGWLJKWQHVVRIWKHFKHVW
  FROODSVH GXHWRFDUGLDFDUUHVW
Ě DQ\VLJQVRIIHYHURULQIHFWLRQ VRUHWKURDWVRUHPRXWKRUXULQDU\SUREOHPV
Ě DQ\unexpectedEUXLVLQJRUEOHHGLQJRUIHHOLQJH[WUHPHO\WLUHGGL]]\RU
EUHDWKOHVVDVWKLVFRXOGPHDQWKDWWRRIHZEORRGFHOOVRIDSDUWLFXODUW\SH
DUHEHLQJSURGXFHG
Ě LI\RXsuddenlyIHHOXQZHOO HYHQZLWKDQRUPDOWHPSHUDWXUH
Ě LI\RXUPXVFOHVDUHDFK\VWLIIRUZHDNand\RXUXULQHLVGDUNHUWKDQXVXDO
RUEURZQRUUHGLQFRORXUĘZKHQ\RXKDYH0HOSKDODQGLUHFWO\LQWR\RXU
DUPRUOHJ
7DONWR\RXUGRFWRULI\RXKDYHDQ\RIWKHIROORZLQJVLGHHIIHFWVZKLFKPD\
DOVRKDSSHQZLWKWKLVPHGLFLQH
Very common (affects more than 1 in 10 people)
Ě DGURSLQWKHQXPEHURIEORRGFHOOVDQGSODWHOHWV
Ě IHHOLQJVLFN QDXVHD EHLQJVLFN YRPLWLQJ DQGGLDUUKRHD
Ě PRXWKXOFHUVZLWKKLJKGRVHVRI0HOSKDODQ
Ě KDLUORVVZLWKKLJKGRVHVRI0HOSKDODQ
Ě DWLQJOLQJRUZDUPIHHOLQJZKHUH0HOSKDODQZDVLQMHFWHG
Ě SUREOHPVZLWK\RXUPXVFOHVOLNHZDVWLQJDQGDFKLQJĘZKHQ\RXKDYH
0HOSKDODQGLUHFWO\LQWR\RXUDUPRUOHJ
Common (affects less than 1 in 10 people)
Ě KDLUORVVZLWKXVXDOGRVHVRI0HOSKDODQ
Ě KLJKOHYHOVRIDFKHPLFDOFDOOHGXUHDLQ\RXUEORRGĘLQSHRSOHZLWKNLGQH\
SUREOHPVZKRDUHEHLQJWUHDWHGIRUP\HORPD
Ě DPXVFOHSUREOHPZKLFKFDQFDXVHSDLQWLJKWQHVVWLQJOLQJEXUQLQJRU
QXPEQHVVĘFDOOHGFRPSDUWPHQWV\QGURPH7KLVFDQKDSSHQZKHQ\RX
KDYH0HOSKDODQGLUHFWO\LQWR\RXUDUPRUOHJ
Rare (affects less than 1 in 1,000 people)
Ě DQLOOQHVVZKHUH\RXKDYHDORZQXPEHURIUHGEORRGFHOOVDVWKH\DUH
EHLQJGHVWUR\HGSUHPDWXUHO\ĘWKLVFDQPDNH\RXIHHOYHU\WLUHGEUHDWKOHVV
DQGGL]]\DQGFDQJLYH\RXKHDGDFKHVRUPDNH\RXUVNLQRUH\HV\HOORZ
Ě OXQJSUREOHPVZKLFKPD\PDNH\RXFRXJKRUZKHH]HDQGPDNHLWGLIILFXOW
WREUHDWKH
Ě OLYHUSUREOHPVZKLFKPD\VKRZXSLQ\RXUEORRGWHVWVRUFDXVHMDXQGLFH
\HOORZLQJRIWKHZKLWHVRIH\HVDQGVNLQ
Ě PRXWKXOFHUVĘZLWKQRUPDOGRVHVRI0HOSKDODQ
Ě VNLQUDVKHVRULWFKLQJVNLQ

LQIHFWLRQLQLPPXQRFRPSURPLVHGKRVWV7KHUHIRUHLPPXQLVDWLRQVZLWKOLYH
RUJDQLVPYDFFLQHVDUHQRWUHFRPPHQGHG
0HOSKDODQ,QMHFWLRQVROXWLRQPD\FDXVHORFDOWLVVXHGDPDJHVKRXOG
H[WUDYDVDWLRQRFFXUDQGFRQVHTXHQWO\LWVKRXOGQRWEHDGPLQLVWHUHGE\GLUHFW
LQMHFWLRQLQWRDSHULSKHUDOYHLQ,WLVUHFRPPHQGHGWKDW0HOSKDODQ,QMHFWLRQ
VROXWLRQLVDGPLQLVWHUHGE\LQMHFWLQJVORZO\LQWRDIDVWUXQQLQJLQWUDYHQRXV
LQIXVLRQYLDDVZDEEHGLQMHFWLRQSRUWRUYLDDFHQWUDOYHQRXVOLQH
,QYLHZRIWKHKD]DUGVLQYROYHGDQGWKHOHYHORIVXSSRUWLYHFDUHUHTXLUHG
WKHDGPLQLVWUDWLRQRIKLJKGRVH0HOSKDODQ,QMHFWLRQVKRXOGEHFRQILQHGWR
VSHFLDOLVWFHQWUHVZLWKWKHDSSURSULDWHIDFLOLWLHVDQGRQO\EHFRQGXFWHGE\
H[SHULHQFHGFOLQLFLDQV
,QSDWLHQWVUHFHLYLQJKLJKGRVH0HOSKDODQ,QMHFWLRQFRQVLGHUDWLRQVKRXOG
EHJLYHQWRWKHSURSK\ODFWLFDGPLQLVWUDWLRQRIDQWLLQIHFWLYHDJHQWVWKH
DGPLQLVWUDWLRQRIEORRGSURGXFWVDVUHTXLUHGDQGWKHPDLQWHQDQFHRIDKLJK
UHQDORXWSXWGXULQJWKHSHULRGLPPHGLDWHO\IROORZLQJWKHDGPLQLVWUDWLRQRI
0HOSKDODQE\WKHXVHRIK\GUDWLRQDQGIRUFHGGLXUHVLV
&RQVLGHUDWLRQVKRXOGEHJLYHQWRHQVXUHDGHTXDWHSHUIRUPDQFHVWDWXVDQG
RUJDQIXQFWLRQEHIRUHXVLQJKLJKGRVH0HOSKDODQ,QMHFWLRQ
Safe handling of Melphalan: 7KHKDQGOLQJRI0HOSKDODQIRUPXODWLRQV
VKRXOGIROORZJXLGHOLQHVIRUWKHKDQGOLQJRIF\WRWR[LFGUXJVDFFRUGLQJWRWKH
5R\DO3KDUPDFHXWLFDO6RFLHW\RI*UHDW%ULWDLQ:RUNLQJ3DUW\RQWKH+DQGOLQJ
RI&\WRWR[LF'UXJV
Monitoring: 6LQFH0HOSKDODQLVDSRWHQWP\HORVXSSUHVVLYHDJHQWLWLV
HVVHQWLDOWKDWFDUHIXODWWHQWLRQVKRXOGEHSDLGWRWKHPRQLWRULQJRIEORRG
FRXQWVWRDYRLGWKHSRVVLELOLW\RIH[FHVVLYHP\HORVXSSUHVVLRQDQGWKHULVN
RILUUHYHUVLEOHERQHPDUURZDSODVLD%ORRGFRXQWVPD\FRQWLQXHWRIDOO
DIWHUWUHDWPHQWLVVWRSSHGVRDWWKHILUVWVLJQRIDQDEQRUPDOO\ODUJHIDOOLQ
OHXNRF\WHRUSODWHOHWFRXQWVWUHDWPHQWVKRXOGEHWHPSRUDULO\LQWHUUXSWHG
0HOSKDODQVKRXOGEHXVHGZLWKFDXWLRQLQSDWLHQWVZKRKDYHXQGHUJRQH
UHFHQWUDGLRWKHUDS\RUFKHPRWKHUDS\LQYLHZRILQFUHDVHGERQHPDUURZ
WR[LFLW\
Renal impairment: 0HOSKDODQFOHDUDQFHPD\EHUHGXFHGLQSDWLHQWVZLWK
UHQDOLPSDLUPHQWZKRPD\DOVRKDYHXUDHPLFERQHPDUURZVXSSUHVVLRQ
'RVHUHGXFWLRQPD\WKHUHIRUHEHQHFHVVDU\ VHHDosage and administratioQ 
DQGWKHVHSDWLHQWVVKRXOGEHFORVHO\REVHUYHG 6HHSide and adverse effects
IRUHOHYDWLRQRIEORRGXUHD 
Mutagenicity: 0HOSKDODQLVPXWDJHQLFLQDQLPDOVDQGFKURPRVRPH
DEHUUDWLRQVKDYHEHHQREVHUYHGLQSDWLHQWVEHLQJWUHDWHGZLWKWKHGUXJ
Carcinogenicity: 0HOSKDODQLQFRPPRQZLWKRWKHUDON\ODWLQJDJHQWV
KDVEHHQUHSRUWHGWREHOHXNDHPRJHQLF7KHUHKDYHEHHQUHSRUWVRIDFXWH
OHXNDHPLDRFFXUULQJDIWHUPHOSKDODQWUHDWPHQWIRUGLVHDVHVVXFKDV
DP\ORLGPDOLJQDQWPHODQRPDPXOWLSOHP\HORPDPDFURJOREXOLQDHPLDFROG
DJJOXWLQLQV\QGURPHDQGRYDULDQFDQFHU
$FRPSDULVRQRISDWLHQWVZLWKRYDULDQFDQFHUZKRUHFHLYHGDON\ODWLQJDJHQWV
ZLWKWKRVHZKRGLGQRWVKRZHGWKDWWKHXVHRIDON\ODWLQJDJHQWVLQFOXGLQJ
PHOSKDODQVLJQLILFDQWO\LQFUHDVHGWKHLQFLGHQFHRIDFXWHOHXNDHPLD
7KHOHXNDHPRJHQLFULVNPXVWEHEDODQFHGDJDLQVWWKHSRWHQWLDOWKHUDSHXWLF
EHQHILWZKHQFRQVLGHULQJWKHXVHRIPHOSKDODQ
Effects on fertility: 0HOSKDODQFDXVHVVXSSUHVVLRQRIRYDULDQIXQFWLRQLQ
SUHPHQRSDXVDOZRPHQUHVXOWLQJLQDPHQRUUKRHDLQDVLJQLILFDQWQXPEHURI
SDWLHQWV
7KHUHLVHYLGHQFHIURPVRPHDQLPDOVWXGLHVWKDW0HOSKDODQFDQKDYHDQ
DGYHUVHHIIHFWRQVSHUPDWRJHQHVLV7KHUHIRUHLWLVSRVVLEOHWKDW0HOSKDODQ
PD\FDXVHWHPSRUDU\RUSHUPDQHQWVWHULOLW\LQPDOHSDWLHQWV
Use in pregnancy and lactation: 7KHWHUDWRJHQLFSRWHQWLDORI0HOSKDODQ
KDVQRWEHHQVWXGLHG,QYLHZRILWVPXWDJHQLFSURSHUWLHVDQGVWUXFWXUDO
VLPLODULW\WRNQRZQWHUDWRJHQLFFRPSRXQGVLWLVSRVVLEOHWKDWPHOSKDODQ
FRXOGFDXVHFRQJHQLWDOGHIHFWVLQWKHRIIVSULQJRISDWLHQWVWUHDWHGZLWKWKH
GUXJ
$VZLWKDOOF\WRWR[LFFKHPRWKHUDS\DGHTXDWHFRQWUDFHSWLYHSUHFDXWLRQV
VKRXOGEHSUDFWLVHGZKHQHLWKHUSDUWQHULVUHFHLYLQJ0HOSKDODQ
7KHXVHRIPHOSKDODQVKRXOGEHDYRLGHGZKHQHYHUSRVVLEOHGXULQJ
SUHJQDQF\SDUWLFXODUO\GXULQJWKHILUVWWULPHVWHU,QDQ\LQGLYLGXDOFDVHWKH
SRWHQWLDOKD]DUGWRWKHIRHWXVPXVWEHEDODQFHGDJDLQVWWKHH[SHFWHGEHQHILW
WRWKHPRWKHU
0RWKHUVUHFHLYLQJ0HOSKDODQVKRXOGQRWEUHDVWIHHG
Side and adverse effects: 8QGHVLUDEOHHIIHFWVPD\YDU\LQWKHLULQFLGHQFH
GHSHQGLQJRQWKHLQGLFDWLRQDQGGRVHUHFHLYHGDQGDOVRZKHQJLYHQLQ
FRPELQDWLRQZLWKRWKHUWKHUDSHXWLFDJHQWV&ODVVLILFDWLRQRIIUHTXHQF\9HU\
FRPPRQĽFRPPRQĽXQFRPPRQĽDQG
UDUHĽDQGYHU\UDUH
Ě Blood and lymphatic system disordersYHU\FRPPRQERQHPDUURZ
GHSUHVVLRQOHDGLQJWROHXFRSHQLDWKURPERF\WRSHQLDDQDHPLDUDUH
KDHPRO\WLFDQDHPLD
Ě Immune system disordersUDUHDOOHUJLFUHDFWLRQVXUWLFDULDRHGHPD
VNLQUDVKHVDQGDQDSK\ODFWLFVKRFNKDYHEHHQUHSRUWHGXQFRPPRQO\
IROORZLQJLQLWLDORUVXEVHTXHQWGRVLQJSDUWLFXODUO\DIWHULQWUDYHQRXV
DGPLQLVWUDWLRQ&DUGLDFDUUHVWKDVDOVREHHQUHSRUWHGUDUHO\LQDVVRFLDWLRQ
ZLWKVXFKHYHQWV
Ě Respiratory, thoracic and mediastinal disordersUDUHLQWHUVWLWLDO
SQHXPRQLWLVDQGSXOPRQDU\ILEURVLV LQFOXGLQJIDWDOUHSRUWV 
Ě Gastrointestinal disordersYHU\FRPPRQQDXVHDYRPLWLQJDQG
GLDUUKRHDVWRPDWLWLVDWKLJKGRVHUDUHVWRPDWLWLVDWFRQYHQWLRQDO
GRVH,QFLGHQFHRIGLDUUKRHDYRPLWLQJDQGVWRPDWLWLVEHFRPHVWKH
GRVHOLPLWLQJWR[LFLW\LQSDWLHQWVJLYHQKLJKLQWUDYHQRXVGRVHVRI
PHOSKDODQLQDVVRFLDWLRQZLWKDXWRORJRXVERQHPDUURZWUDQVSODQWDWLRQ
&\FORSKRVSKDPLGHSUHWUHDWPHQWDSSHDUVWRUHGXFHWKHVHYHULW\&RQVXOW
WKHOLWHUDWXUHIRUGHWDLOV

7KHIROORZLQJVLGHHIIHFWVDOVRKDSSHQZLWK0HOSKDODQ
Ě OHXNDHPLDĘFDQFHURIWKHEORRG
Ě LQZRPHQ\RXUSHULRGVVWRSSLQJ
,IDQ\RIWKHVLGHHIIHFWVJHWVVHULRXVRULI\RXQRWLFHDQ\VLGHHIIHFWVQRW
OLVWHGLQWKLVOHDIOHWSOHDVHWHOO\RXUGRFWRURUSKDUPDFLVW
5 How to store Melphalan
Ě .HHSRXWRIWKHUHDFKDQGVLJKWRIFKLOGUHQ
Ě 'RQRWXVH0HOSKDODQDIWHUWKHH[SLU\GDWHZKLFKLVVWDWHGRQWKHSDFN
DIWHUĎ([Sď
Ě 'RQRWVWRUH0HOSKDODQ,QMHFWLRQDERYHŃ&'RQRWUHIULJHUDWH.HHSWKH
YLDOLQWKHRXWHUFDUWRQWRSURWHFWIURPOLJKW
Ě  SURIHVVLRQDO2QFHSUHSDUHGLWVKRXOGEHXVHGLPPHGLDWHO\DQGPXVWQRW
EHVWRUHGRUUHIULJHUDWHG
6 Further information
What Melphalan contains
7KHDFWLYHLQJUHGLHQWLVPHOSKDODQ(DFK0HOSKDODQLQMHFWLRQFRQWDLQVPJ
RIPHOSKDODQ
7KHRWKHULQJUHGLHQWVDUHSRYLGRQH.DQGK\GURFKORULFDFLG0HOSKDODQ
LVGLVVROYHGLQDGLOXHQWEHIRUHEHLQJLQMHFWHG7KHGLOXHQWFRQWDLQVZDWHU
VRGLXPFLWUDWHSURS\OHQHJO\FRODQGHWKDQRO
What Melphalan looks like and contents of the pack
(DFKSDFNFRQWDLQVRQH0HOSKDODQ,QMHFWLRQYLDODQGRQH0HOSKDODQ
,QMHFWLRQ'LOXHQWYLDO
Marketing Authorisation Holder and Manufacturer
0DUNHWLQJ$XWKRULVDWLRQKROGHU
$VSHQ3KDUPD7UDGLQJ/LPLWHG
/DNH'ULYH
&LW\ZHVW%XVLQHVV&DPSXV
'XEOLQ,UHODQG
0DQXIDFWXUHU*OD[R6PLWK.OLQH0DQXIDFWXULQJ6S$6DQ3RORGL7RUULOH
3DUPD,WDO\
Other formats:
7ROLVWHQWRRUUHTXHVWDFRS\RIWKLVOHDIOHWLQ%UDLOOHODUJHSULQWRUDXGLR
SOHDVHFDOOIUHHRIFKDUJH
 8.RQO\ 
3OHDVHEHUHDG\WRJLYHWKHIROORZLQJLQIRUPDWLRQ
Product name Melphalan 50 mg Powder and Solvent for Solution for
Injection/Infusion.5HIHUHQFHQXPEHU3/
7KLVLVDVHUYLFHSURYLGHGE\WKH5R\DO1DWLRQDO,QVWLWXWHRIWKH%OLQG
/HDIOHWGDWH
 
  

Ě Hepatobiliary disordersUDUHKHSDWLFGLVRUGHUVUDQJLQJIURPDEQRUPDO
OLYHUIXQFWLRQWHVWVWRFOLQLFDOPDQLIHVWDWLRQVVXFKDVKHSDWLWLVDQG
MDXQGLFHYHQRRFFOXVLYHGLVHDVHIROORZLQJKLJKGRVHWUHDWPHQW
Ě Skin and subcutaneous tissue disordersYHU\FRPPRQDORSHFLDDW
KLJKGRVHFRPPRQDORSHFLDDWFRQYHQWLRQDOGRVHUDUHPDFXORSDSXODU
UDVKHVDQGSUXULWXV
Ě Musculoskeletal and connective tissue disorders,QMHFWLRQIROORZLQJ
LVRODWHGOLPESHUIXVLRQYHU\FRPPRQPXVFOHDWURSK\PXVFOHILEURVLV
P\DOJLDEORRGFUHDWLQHSKRVSKRNLQDVHLQFUHDVHGFRPPRQFRPSDUWPHQW
V\QGURPHLQFLGHQFHQRWNQRZQPXVFOHQHFURVLVUKDEGRP\RO\VLV
Ě Renal and urinary disordersFRPPRQWHPSRUDU\VLJQLILFDQWHOHYDWLRQ
RIWKHEORRGXUHDKDVEHHQVHHQLQWKHHDUO\VWDJHVRIPHOSKDODQWKHUDS\
LQP\HORPDSDWLHQWVZLWKUHQDOGDPDJH
Ě General disorders and administration site conditionsYHU\FRPPRQ
VXEMHFWLYHDQGWUDQVLHQWVHQVDWLRQRIZDUPWKDQGRUWLQJOLQJ
Drug interactions: 1DOLGL[LFDFLGWRJHWKHUZLWKKLJKGRVHLQWUDYHQRXV
PHOSKDODQKDVFDXVHGGHDWKVLQFKLOGUHQGXHWRKDHPRUUKDJLFHQWHURFROLWLV
,PSDLUHGUHQDOIXQFWLRQKDVEHHQGHVFULEHGLQERQHPDUURZWUDQVSODQW
SDWLHQWVZKRZHUHFRQGLWLRQHGZLWKKLJKGRVHLQWUDYHQRXVPHOSKDODQDQG
ZKRVXEVHTXHQWO\UHFHLYHGFLFORVSRULQWRSUHYHQWJUDIWYHUVXVKRVWGLVHDVH
Toxicity and treatment of overdosage: 7KHLPPHGLDWHHIIHFWVRIDFXWH
LQWUDYHQRXVRYHUGRVDJHDUHQDXVHDDQGYRPLWLQJ'DPDJHWRWKHJDVWUR
LQWHVWLQDOPXFRVDPD\DOVRHQVXHDQGGLDUUKRHDVRPHWLPHVKDHPRUUKDJLF
KDVEHHQUHSRUWHGDIWHURYHUGRVDJH7KHSULQFLSDOWR[LFHIIHFWLVERQHPDUURZ
VXSSUHVVLRQOHDGLQJWROHXFRSHQLDWKURPERF\WRSHQLDDQGDQDHPLD
*HQHUDOVXSSRUWLYHPHDVXUHVWRJHWKHUZLWKDSSURSULDWHEORRGDQGSODWHOHW
WUDQVIXVLRQVVKRXOGEHLQVWLWXWHGLIQHFHVVDU\DQGFRQVLGHUDWLRQJLYHQWR
KRVSLWDOLVDWLRQDQWLELRWLFFRYHUDQGWKHXVHRIKDHPDWRORJLFDOJURZWK
IDFWRUV
7KHUHLVQRVSHFLILFDQWLGRWH7KHEORRGSLFWXUHVKRXOGEHFORVHO\PRQLWRUHG
IRUDWOHDVWIRXUZHHNVIROORZLQJRYHUGRVDJHXQWLOWKHUHLVHYLGHQFHRI
UHFRYHU\
Pharmaceutical precautions
Injection unit pack: 6WRUHEHORZŃ&3URWHFWIURPOLJKW'RQRWUHIULJHUDWH
0HOSKDODQ,QMHFWLRQVXUSOXVWRUHTXLUHPHQWVVKRXOGEHGHVWUR\HGLQD
PDQQHUDSSURSULDWHWRWKHSUHYDLOLQJORFDOUHJXODWRU\UHTXLUHPHQWVIRUWKH
GLVSRVDORIF\WRWR[LFGUXJV
Legal category
320
Package quantities
Injection unit pack: 9LDORI0HOSKDODQIUHH]HGULHGSRZGHUDQGYLDORI
VROYHQWGLOXHQW
Further information
1LO
Product licence numbers
Injection: 3/
Solvent-Diluent:3/
7KHOHDIOHWZDVODVWUHYLVHGLQ

 
  



Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide